TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD Disclosure
Item 7.01

Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.01 2 ex99-01.htm CORPORATE PRESENTATION BY THE COMPANY FOR MARCH 2021   Tonix Pharmaceuticals Holding Corp. 8-K   Exhibit 99.01 © 2021 Tonix Pharmaceuticals Holding Corp. 1 March 2021 Version P0276 3 – 3 – 2021 (Doc 0789) Investor Presentation NASDAQ:TNXP     © 2021 Tonix Pharmaceuticals Holding Corp. 2 Cautionary Note on Forward – Looking Statements Certain statements in this presentation regarding strategic plans,…
To view the full exhibit click here